Home  >  Companies  >  Hinge Health
Hinge Health
Digital healthcare provider specializing in musculoskeletal disorders

Revenue

$390.40M

2024

Growth Rate (y/y)

33%

2024

Funding

$847.25M

2021

Details
Headquarters
San Francisco, CA
CEO
Daniel Perez
Website
Listed In

Revenue

None

Sacra estimates Hinge Health hit $390M in revenue in 2024, growing 33% year-over-year from $293M in 2023.

Hinge Health primarily generates revenue from self-insured employers through annual subscriptions, with clients only paying for members who engage with their MSK programs. Revenue is recognized ratably over 12 months once members enroll. The company has recently introduced an engagement-based pricing model with an upfront platform fee plus per-session charges.

With 2,256 clients as of December 31, 2024 (up 36% YoY), Hinge Health serves 49% of Fortune 100 companies and 42% of Fortune 500 companies. Their impressive 98% client retention rate and 117% net dollar retention demonstrate strong customer satisfaction and expansion.

The company is actively diversifying revenue streams by expanding into fully-insured employers and Medicare Advantage markets through partnerships with five national health plans. Their international expansion began with Canada in Q3 2024, with European launches planned for 2025.

Hinge Health's financial profile has strengthened significantly, with gross margins improving from 66% in 2023 to 77% in 2024. The company generated $49M in operating cash flow and $45M in free cash flow in 2024, while reducing its net loss by 89% to just $12M.

Valuation

Hinge Health has raised a total of $1.05B in funding to date. The company was last valued at $6.2B following its $600M Series E round in October 2021, led by Tiger Global and Coatue Management. Based on Hinge Health's 2024 revenue of $390.4M, this represents a valuation multiple of approximately 15.9x LTM revenue.

Product

Hinge Health was founded in 2014 by Daniel Perez and Gabriel Mecklenburg to address musculoskeletal (MSK) pain through digital physical therapy.

Hinge Health found product-market fit as a digital MSK care platform for self-insured employers seeking to reduce healthcare costs while improving employee outcomes for conditions like back and knee pain.

The platform delivers personalized physical therapy programs through a mobile app, combining AI-powered motion tracking technology with clinical support. Members receive a kit with wearable sensors that provide real-time feedback during exercises, ensuring proper form. The platform's computer vision technology tracks over 100 points on the body to assess range of motion and guide corrections.

Care is designed by physical therapists but largely automated through AI, allowing members to engage on-demand without scheduling constraints. The platform addresses the full spectrum of MSK needs, from prevention to chronic pain management and post-surgical rehabilitation.

Hinge Health has expanded its offerings to include: • Women's pelvic health program for specialized care • Fall prevention program targeting Medicare Advantage populations • HingeConnect for integrating with electronic health records and coordinating care with providers

The platform is typically offered at no direct cost to members, fully covered by their employers or health plans.

Business Model

Hinge Health is a digital musculoskeletal (MSK) care platform that connects self-insured employers and health plans with comprehensive solutions for treating and preventing joint and muscle pain. The company operates on an annual subscription model where clients pay only for members who actively engage with their programs.

Revenue is generated through an engagement-based pricing structure that typically includes an annual upfront platform fee per eligible member plus additional fees for completed therapy sessions. Hinge Health has recently introduced alternative pricing models, including milestone-based payments tied to member engagement.

The platform leverages AI-powered motion tracking technology to automate personalized care plans, reducing human physical therapy hours by approximately 95% while maintaining high-quality outcomes. This technology-first approach enables Hinge Health to achieve impressive gross margins of 77-78%.

Hinge Health primarily targets self-insured employers, including 49% of Fortune 100 and 42% of Fortune 500 companies. The company is actively expanding into fully-insured employers, Medicare Advantage markets, and federal insurance plans through strategic partnerships with major health plans and PBMs.

The sales cycle averages 5 months but can exceed 12 months for larger enterprise clients. Most contracts are secured in the second half of the calendar year to align with employee benefit enrollment periods, with platform launches typically occurring in the first half of the following year.

Hinge Health's competitive advantage stems from its AI-powered technology platform, comprehensive MSK care programs covering conditions from neck to feet, and specialized offerings like women's pelvic health and fall prevention programs. The company's HingeConnect feature integrates with EHR data from over 750,000 providers, enabling targeted interventions for high-risk individuals and strengthening its position as the preferred digital MSK solution.

Competition

Hinge Health operates in a market that includes digital musculoskeletal (MSK) care providers, traditional physical therapy networks, and integrated healthcare platforms. The competitive landscape has evolved rapidly as employers and health plans seek solutions to address the $1.3 trillion annual burden of MSK conditions in the United States.

Digital MSK specialists

Sword Health offers a similar digital physical therapy solution with motion tracking technology and virtual care teams. Unlike Hinge Health's comprehensive platform approach, Sword focuses primarily on physical therapy and pain management.

SWORD has raised significant funding ($163M Series D in 2021) but lacks Hinge Health's scale of 20 million contracted lives and partnerships with all five major national health plans.

Kaia Health provides a smartphone-based solution that uses computer vision for movement tracking without specialized sensors. Their approach offers greater accessibility but potentially less precision than Hinge Health's TrueMotion technology.

RecoveryOne (formerly Trainer Rx) focuses on virtual MSK recovery with personalized exercise programs and telehealth coaching. They differentiate by emphasizing recovery from specific injuries rather than Hinge Health's broader chronic pain management approach.

Traditional physical therapy networks

Major physical therapy chains like ATI Physical Therapy, Select Physical Therapy, and CORA Health Services represent the traditional in-person approach to MSK care. These providers typically operate through insurance networks with higher patient costs and less convenience than digital solutions.

Traditional providers have begun incorporating telehealth components, particularly following COVID-19, but lack the AI-driven personalization and motion tracking capabilities of digital-first platforms.

Integrated healthcare platforms

Omada Health started as a digital diabetes prevention program but has expanded into MSK care through its 2020 acquisition of Physera. This positions them as a comprehensive digital health solution addressing multiple chronic conditions.

Teladoc Health offers virtual MSK care as part of its broader telehealth platform. Their acquisition of Livongo (2020) strengthened their chronic condition management capabilities, though their MSK offering lacks the specialized technology and depth of Hinge Health.

Grand Rounds Health (now Included Health) provides navigation services connecting patients to appropriate care, including MSK specialists. They compete less directly but influence referral patterns to specialized MSK providers.

Major health insurers have also developed in-house digital MSK programs, though these typically lack the technological sophistication of dedicated providers like Hinge Health. UnitedHealth Group's Optum has invested significantly in virtual care capabilities that include MSK management.

TAM Expansion

Hinge Health has tailwinds from the massive MSK care market, digital health adoption, and value-based care trends. The company has the opportunity to grow and expand into adjacent markets like women's health, global markets, and Medicare/Medicaid populations.

Core MSK market penetration

Hinge Health currently addresses only 5% of its total addressable market with 20 million contracted lives. The MSK care market represents a $661 billion annual direct spend in the U.S. alone, with an additional $624 billion in indirect costs. This creates a $1.3 trillion total MSK burden.

The company's current self-insured employer market represents approximately $10 billion in opportunity. With 98% client retention and 117% net dollar retention, Hinge Health demonstrates strong product-market fit within its core business. The company has already secured 49% of Fortune 100 companies and 42% of Fortune 500 companies as clients.

Hinge Health's AI-powered motion tracking technology has reduced human care team hours by approximately 95% compared to traditional physical therapy, creating a scalable, high-margin solution (78% non-GAAP gross margin).

Adjacent market opportunities

Fully-insured employers and Medicare Advantage plans represent an $8 billion addressable market with 96 million additional lives. Hinge Health has already begun expanding into these markets through partnerships with all five major national health plans.

Government agencies and healthcare programs (Medicare/Medicaid) offer another $9 billion opportunity with 112 million lives. The company's fall prevention program specifically targets the Medicare Advantage population.

Women's health represents a significant expansion opportunity. Hinge Health launched a women's pelvic health program in 2022 and expanded to menopause support in 2024, addressing underserved segments with specialized MSK care needs.

International expansion

Hinge Health has begun its global expansion, launching in Canada in Q3 2024 with plans to enter several European markets in the first half of 2025. The global MSK market is substantial, with an estimated 1.7 billion people worldwide affected by MSK conditions.

The company's technology platform is well-positioned for international scaling. Its AI-driven approach reduces reliance on human providers, allowing for more efficient expansion across borders. The platform's ability to track over 100 unique points on the body creates a technological moat that can be leveraged globally.

With strong unit economics (33% YoY revenue growth, improving gross margins from 66% to 77%), Hinge Health has the financial foundation to support this expansion while maintaining its path toward profitability.

Risks

Dependence on employer-sponsored healthcare model: Hinge Health's business is heavily reliant on self-insured employers, with 98% client retention and 117% net dollar retention as of December 2024. While this has fueled growth to date, any significant shift in how employers approach healthcare benefits or increased pressure to reduce benefit costs during economic downturns could severely impact Hinge Health's revenue and growth trajectory.

Engagement-based pricing challenges: Hinge Health's transition to an engagement-based pricing model with platform fees plus per-session charges creates revenue uncertainty. If member engagement falls below expectations or the company fails to effectively monetize engagement, revenue could decline significantly, especially given that clients only pay for members who actively engage with programs.

Competitive commoditization of digital MSK care: As Hinge Health expands into new markets like Medicare Advantage and international territories, it faces increasing competition from both digital health startups and traditional healthcare providers developing similar solutions. The company's current technological advantages in AI-powered motion tracking could be replicated, potentially eroding its premium pricing position and 77% gross margins.

Funding Rounds

Share Name Issue Price Issued At
Series E $77.46 Oct 2021
Share Name Issue Price Issued At
Series D $43.72 Jan 2021
Share Name Issue Price Issued At
Series C $7.31 Feb 2020
Series C-1 $6.77 Feb 2020
Share Name Issue Price Issued At
Series B $2.26 Jul 2018
Share Name Issue Price Issued At
Series A-2 $1.03 Jul 2017
Series A-1 $0.83 Jul 2017
Share Name Issue Price Issued At
Series Seed-2 $0.42 Apr 2017
Series Seed-1 $0.34 Apr 2016
View the source Certificate of Incorporation copy.

News

DISCLAIMERS

This report is for information purposes only and is not to be used or considered as an offer or the solicitation of an offer to sell or to buy or subscribe for securities or other financial instruments. Nothing in this report constitutes investment, legal, accounting or tax advice or a representation that any investment or strategy is suitable or appropriate to your individual circumstances or otherwise constitutes a personal trade recommendation to you.

This research report has been prepared solely by Sacra and should not be considered a product of any person or entity that makes such report available, if any.

Information and opinions presented in the sections of the report were obtained or derived from sources Sacra believes are reliable, but Sacra makes no representation as to their accuracy or completeness. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. Information, opinions and estimates contained in this report reflect a determination at its original date of publication by Sacra and are subject to change without notice.

Sacra accepts no liability for loss arising from the use of the material presented in this report, except that this exclusion of liability does not apply to the extent that liability arises under specific statutes or regulations applicable to Sacra. Sacra may have issued, and may in the future issue, other reports that are inconsistent with, and reach different conclusions from, the information presented in this report. Those reports reflect different assumptions, views and analytical methods of the analysts who prepared them and Sacra is under no obligation to ensure that such other reports are brought to the attention of any recipient of this report.

All rights reserved. All material presented in this report, unless specifically indicated otherwise is under copyright to Sacra. Sacra reserves any and all intellectual property rights in the report. All trademarks, service marks and logos used in this report are trademarks or service marks or registered trademarks or service marks of Sacra. Any modification, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, or selling any report is strictly prohibited. None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or distributed to any other party, without the prior express written permission of Sacra. Any unauthorized duplication, redistribution or disclosure of this report will result in prosecution.